Stock Events

Stock Events

Search...

Recursion Pharmaceuticals (RXRX) Q2 2025 Earnings

5MayConfirmed

Q3 2024

Q4 2024

Q1 2025

Q2 2025

-0.53

-0.46

-0.4

-0.33

Details

Expected EPS

-0.516

Actual EPS

-0.5

Surprise EPS

0.02

Surprise Percent

+3.1%

Description

Recursion Pharmaceuticals (RXRX) has reported earnings of -0.5 per share for Q2 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.